28th February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj...
A director at Animalcare Group sold 13,857,213 shares at 285p and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Benchmark is delivering on its strategic aims, having largely completed its disposals program of non-core or unprofitable operations and sharpening the focus on its core, aquaculture. The disposals will raise up to £44m, reinforcing the Company’s financial position to weather uncertainties related to the pandemic, to invest selectively in its core business and to enable liquidity to remain well within the covenant terms of its NOK bond loan. Actions taken have been as the new management team ...
Benchmark (BMK) helps deliver improved healthcare products and services to the Animal Health and Aquaculture industry. Rising demand from clients for its products and services to manage sustainability practice in worldwide production and supply chains underlines BMK’s opportunity for significant organic and external growth. The company held a well-attended Capital Markets Day (CMD) on 27 March, which highlighted its strategic targets for fulfilling its growth potential spanning Advanced Nutri...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Animalcare continues to perform very much as expected, with the FY15 trading update showing a 5.1% rise in group revenues to £13.54m. This was driven by the 8.8% increase in Licensed Veterinary Medicines to £8.58m, with Companion Animal Identification down 4.5% to £2.31m and Animal Welfare up 2.6% to £2.65m. Underlying operating profit is expected to be at least £3.0m, slightly higher than our forecast. Cash generation remains strong, higher than expected, with cash of £5.78m at June 2015....
Animalcare’s trading update confirms it is performing as we expected. The 7.2% rise (y-o-y) in group revenues was driven by a 10.6% increase in Licensed Veterinary Medicines. Three new product introductions are planned for H215. Companion Animal Identification revenues were up 5.0%, while the continuing streamlining of the Animal Welfare portfolio saw revenues drop 1%, but profitability was increased slightly. Cash generation remains strong, with cash of c £5.0m at December 2014. Our DCF valu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.